Tag: Quarter

Geron Corporation Reports Third Quarter 2024 Financial Results and Recent Business Highlights

Achieved $28.2 million in RYTELO™ (imetelstat) net product revenue in first full quarter of sales

Received $250 million in gross proceeds from synthetic royalty and debt financings with Royalty Pharma and Pharmakon Advisors, with access to an additional $125 million …

Back To Top